Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Ultrapro Biotechnology Proshares (UBIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fund basics

See More
  • Fund Family ProShares
  • Assets Under Management 53,646,900
  • Shares Outstanding, K 1,300
  • Annual Dividend Yield 0.00%
  • Price/Earnings ttm 21.05
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
36.68 +9.54%
on 09/22/17
41.81 -3.90%
on 10/06/17
+2.06 (+5.40%)
since 09/15/17
3-Month
29.25 +37.37%
on 08/18/17
41.81 -3.90%
on 10/06/17
+6.89 (+20.70%)
since 07/17/17
52-Week
17.67 +127.39%
on 11/04/16
41.81 -3.90%
on 10/06/17
+17.89 (+80.26%)
since 10/17/16

Most Recent Stories

More News
Should You Keep Your Portfolio Healthy with Biotech ETFs?

Biotech ETFs are riding high on research and developments and FDA approvals.

BBC : 28.78 (unch)
CNCR : 26.47 (-1.38%)
IBB : 338.12 (+0.38%)
VRTX : 155.05 (+0.23%)
BBH : 135.77 (+0.47%)
LABU : 85.88 (-0.46%)
K : 61.74 (-0.27%)
BBP : 41.82 (+0.63%)
SBIO : 31.44 (-0.32%)
UBIO : 40.18 (+1.16%)
CLVS : 81.32 (-3.85%)
BIB : 62.80 (+0.75%)
GILD : 80.24 (+0.36%)
SPY : 255.47 (+0.07%)
XBI : 86.74 (-0.21%)
Should You Keep Your Portfolio Healthy with Biotech ETFs?

Biotech ETFs are riding high on research and developments and FDA approvals.

BBC : 28.78 (unch)
CNCR : 26.47 (-1.38%)
IBB : 338.12 (+0.38%)
VRTX : 155.05 (+0.23%)
BBH : 135.77 (+0.47%)
LABU : 85.88 (-0.46%)
K : 61.74 (-0.27%)
BBP : 41.82 (+0.63%)
SBIO : 31.44 (-0.32%)
UBIO : 40.18 (+1.16%)
CLVS : 81.32 (-3.85%)
BIB : 62.80 (+0.75%)
GILD : 80.24 (+0.36%)
SPY : 255.47 (+0.07%)
XBI : 86.74 (-0.21%)
5 Reasons Why Biotech ETFs are Soaring

Reasons that propelled the biotech space and the related ETFs higher.

BBP : 41.82 (+0.63%)
BBC : 28.78 (unch)
UBIO : 40.18 (+1.16%)
IBB : 338.12 (+0.38%)
BBH : 135.77 (+0.47%)
CLVS : 81.32 (-3.85%)
BIB : 62.80 (+0.75%)
LABU : 85.88 (-0.46%)
XBI : 86.74 (-0.21%)
5 Reasons Why Biotech ETFs are Soaring

Reasons that propelled the biotech space and the related ETFs higher.

BBP : 41.82 (+0.63%)
BBC : 28.78 (unch)
UBIO : 40.18 (+1.16%)
IBB : 338.12 (+0.38%)
BBH : 135.77 (+0.47%)
CLVS : 81.32 (-3.85%)
BIB : 62.80 (+0.75%)
LABU : 85.88 (-0.46%)
XBI : 86.74 (-0.21%)
4 Stocks & ETFs to Buy on Clovis' Positive Drug Data

Clovis Oncology clinical trial data has given a boost to the biotech sector and put these stocks and ETFs in focus.

BBC : 28.78 (unch)
CLDX : 3.00 (-2.28%)
CNCR : 26.47 (-1.38%)
IBB : 338.12 (+0.38%)
LABU : 85.88 (-0.46%)
KITE : 179.99 (+0.11%)
CGIX : 2.70 (unch)
BBP : 41.82 (+0.63%)
SBIO : 31.44 (-0.32%)
UBIO : 40.18 (+1.16%)
INCY : 115.64 (-0.82%)
CLVS : 81.32 (-3.85%)
BIB : 62.80 (+0.75%)
XBI : 86.74 (-0.21%)
4 Stocks & ETFs to Buy on Clovis' Positive Drug Data

Clovis Oncology clinical trial data has given a boost to the biotech sector and put these stocks and ETFs in focus.

BBC : 28.78 (unch)
CLDX : 3.00 (-2.28%)
CNCR : 26.47 (-1.38%)
IBB : 338.12 (+0.38%)
LABU : 85.88 (-0.46%)
KITE : 179.99 (+0.11%)
CGIX : 2.70 (unch)
BBP : 41.82 (+0.63%)
SBIO : 31.44 (-0.32%)
UBIO : 40.18 (+1.16%)
INCY : 115.64 (-0.82%)
CLVS : 81.32 (-3.85%)
BIB : 62.80 (+0.75%)
XBI : 86.74 (-0.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Fund Summary

ProShares UltraPro Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the NASDAQ Biotechnology Index.

See More

Support & Resistance

2nd Resistance Point 41.17
1st Resistance Point 40.68
Last Price 40.18
1st Support Level 39.65
2nd Support Level 39.11

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart